Latest filing published 05 Mar 2018 for Expres2ion Biotech AB.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Allan Rosetzsky: trading record in brief
Allan Rosetzsky is a declared insider of Expres2ion Biotech AB, with filings sourced from Finansinspektionen. We count 3 filings; the first trade dates from 30 June 2017 and the latest from 27 February 2018.
The open-market side counts 2 purchases for €3,307 alongside 1 sale. No amount is published for 1 filing, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2018, the count stands at 2 purchases and 1 sale.
Most recently, on 5 March 2018, the filings show an open-market sale in Expres2ion Biotech AB. The latest purchase dates back some time: it was published 3,169 days ago, on 5 March 2018. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Allan Rosetzsky
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 707,634 shares0FI:csv-33e133766578166adf34
- 16,800 shares@ SEK 1.264.7% of flowFI:csv-0c8ce4854f656cd2861aCanonical exit: 29 Dec 2017 (T+90)
- 8,400 shares@ SEK 1.262.3% of flowFI:csv-fb7f4f0b13ffa714cedbCanonical exit: 28 Sept 2017 (T+90)
3 of 3 declarations